SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: Dave Sullivan who wrote (425)4/26/1999 3:57:00 PM
From: LLCF  Read Replies (2) | Respond to of 712
 
< They have a product on the market,moving rapidly to profitability, and their focus on cardiovascular disease is attractive to a company like Chiron, also note Chiron's Chief Scientific Officer was the scientific founder of corr.>

Have you visited the "Munch a Bunch" thread???

Subject 24574

Input would be appreciated by all.

DAK



To: Dave Sullivan who wrote (425)4/26/1999 5:45:00 PM
From: RCMac  Respond to of 712
 
Dave, >> This is . . . from an article I read in Dick Davis Digest<<

Actually, it's from Jim McCamant's MTSL, 3/11/99 issue:
Message 8331825

While I worry a little about our quoting other people's copyrighted stuff in SI posts, we should probably worry even more about it if we mistakenly attribute it to one of the author's competitors. <g>

RCM


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News